Literature DB >> 23393337

Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinoma.

Shingo Nakashima1, Atsushi Shiozaki, Daisuke Ichikawa, Shuhei Komatsu, Hirotaka Konishi, Daisuke Iitaka, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eigo Otsuji.   

Abstract

BACKGROUND: The immunohistochemical staining of phospho-histone H3 (PHH3) has recently been reported to predict the prognosis of different tumors. However, it has not been evaluated in esophageal squamous cell carcinoma (ESCC). The aim of this study was to evaluate the prognostic impact of PHH3 in ESCC.
MATERIALS AND METHODS: The number of anti-phophohistone H3-positive nuclei [i.e. PHH3 mitotic index (MI)] was calculated by immunohistochemistry of 50 primary tumor samples obtained from patients with ESCC who underwent curative esophagectomy.
RESULTS: The PHH3 MI per 10 high-power fields ranged from 1 to 72 (median=15.5). When the patients were divided into two groups using a cut-off value of 10, the 5-year survival rate of the patients with PHH3 MI ≤10 was significantly higher than that of patients with PHH3 MI >10. Multivariate analysis indicated PHH3 MI to be an independent prognostic factor.
CONCLUSION: The expression of PHH3 impacts the prognosis of patients with ESCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23393337

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?

Authors:  Shafqat Ali Khan; Divya Reddy; Sanjay Gupta
Journal:  World J Biol Chem       Date:  2015-11-26

2.  Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Authors:  Eleonora Duregon; Adele Cassenti; Alessandra Pittaro; Laura Ventura; Rebecca Senetta; Roberta Rudà; Paola Cassoni
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

3.  High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas.

Authors:  Pramila Ramani; Scott Taylor; Elizabeth Miller; Emile Sowa-Avugrah; Margaret T May
Journal:  J Histochem Cytochem       Date:  2015-02-23       Impact factor: 2.479

4.  The K-Cl cotransporter KCC3 as an independent prognostic factor in human esophageal squamous cell carcinoma.

Authors:  Atsushi Shiozaki; Kenichi Takemoto; Daisuke Ichikawa; Hitoshi Fujiwara; Hirotaka Konishi; Toshiyuki Kosuga; Shuhei Komatsu; Kazuma Okamoto; Mitsuo Kishimoto; Yoshinori Marunaka; Eigo Otsuji
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

5.  PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors.

Authors:  Yooju Shin; Jiyeon Hyeon; Boram Lee; Sang Yun Ha; Min Eui Hong; In Gu Do; Kyoung-Mee Kim
Journal:  J Pathol Transl Med       Date:  2015-01-15

6.  Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade.

Authors:  Elham Mirzaiian; Zahra Sadat Tabatabaei Ghods; Seyed Mohammad Tavangar; Binesh Emami; Maryam Oraie; Roya Safyari; Hiva Saffar
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

Review 7.  Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.

Authors:  Dorota Komar; Przemyslaw Juszczynski
Journal:  Clin Epigenetics       Date:  2020-10-14       Impact factor: 6.551

8.  PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer.

Authors:  Akira Koshino; Aya Nagano; Akinobu Ota; Toshinori Hyodo; Akane Ueki; Masayuki Komura; Akane Sugimura-Nagata; Masahide Ebi; Naotaka Ogasawara; Kenji Kasai; Yoshitaka Hosokawa; Kunio Kasugai; Satoru Takahashi; Shingo Inaguma
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

9.  The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer.

Authors:  Kazuhiro Nagao; Akira Koshino; Akane Sugimura-Nagata; Aya Nagano; Masayuki Komura; Akane Ueki; Masahide Ebi; Naotaka Ogasawara; Toyonori Tsuzuki; Kenji Kasai; Satoru Takahashi; Kunio Kasugai; Shingo Inaguma
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.